Skip to main content

Table 3 Baseline characteristics of the included patients according to the GS tertiles

From: Predictive efficacy of neutrophil-to-lymphocyte ratio for long-term prognosis in new onset acute coronary syndrome: a retrospective cohort study

  1st tertile ≤ 45 (n = 250) 2nd tertile 49–85 (n = 246) 3rd tertile ≥ 85 (n = 241) t/Z/χ2 P
Sex (male/female) 171/79 191/55 200/41 14.814 0.001
Age (years) 55.37 ± 12.26 58.23 ± 11.84a 60.53 ± 12.34ab 11.111  < 0.001
Hypertension 106 (42.4) 111 (45.1) 114 (47.3) 1.199 0.549
Diabetes mellitus 45 (18.0) 66 (26.8) 82 (34.0)ab 16.381  < 0.001
Diabetes mellitus treatment     0.846 0.932
 Diet only 2 (4.2) 3 (6.7) 3 (4.7)   
 Oral hypoglycemic drugs 23 (47.9) 19 (42.2) 32 (50.0)   
 Insulin 23 (47.9) 23 (51.1) 29 (45.3)   
Smoking     9.963 0.041
 Never smoker 134 (53.6) 119 (48.4) 104 (43.2)   
 Former smoker 16 (6.4) 13 (5.3) 8 (3.3)   
 Current smoker 100 (40.0) 114 (46.3) 129 (53.5)   
Alcohol drinking     1.053 0.902
 Never drinking 147 (58.8) 153 (63.2) 146 (60.6)   
 Former drinking 41 (16.4) 36 (14.9) 39 (16.2)   
 Current drinking 62 (24.8) 53 (21.9) 56 (23.2)   
Family history of CAD 95 (38.0) 100 (40.7) 102 (42.3) 0.972 0.615
SBP (mmHg) 123.72 ± 20.64 122.37 ± 18.87 121 ± 19.85 1.157 0.315
DBP (mmHg) 76.86 ± 13.88 77.45 ± 13.12 75.62 ± 13.3 1.174 0.310
Heart rate 80.42 ± 14.05 81.78 ± 14.26 83.68 ± 16.58 2.930 0.054
BMI (kg/m2) 24.78 ± 5.95 24.9 ± 5.05 25.11 ± 5.36 0.203 0.817
HDL-C (mmol/l) 0.96 ± 0.23 0.99 ± 0.26 1.01 ± 0.28 2.152 0.117
LDL-C (mmol/l) 2.88 ± 0.85 2.94 ± 0.74 3.04 ± 1 1.434 0.239
TC (mmol/l) 4.63 ± 1.23 4.57 ± 0.98 4.68 ± 1.34 0.374 0.688
TG (mmol/l) 2.14 ± 2.15 2.15 ± 2.13 1.98 ± 1.45 0.426 0.653
ApoA1 (g/L) 1.2 ± 0.26 1.23 ± 0.3 1.29 ± 0.53 2.710 0.067
ApoB (g/L) 0.9 ± 0.27 0.88 ± 0.23 0.96 ± 0.52 2.433 0.089
Lp(a) (g/L) 234.48 ± 232.84 263.47 ± 280.29 222 ± 172.39 1.505 0.223
Cr (mmol/L) 80.9 ± 35.25 80.52 ± 42.9 78.84 ± 52.29 0.150 0.860
BUN (mmol/l) 5.71 ± 2.91 5.59 ± 2.87 5.5 ± 1.95 0.394 0.674
Uric acid (μmol/L) 326.22 ± 92.64 335.89 ± 94.27 324.19 ± 92.59 1.090 0.337
WBC 10.88 ± 3.74 10.87 ± 3.71 10.64 ± 3.29 0.339 0.712
Neutrophil count 8.13 ± 3.63 8.37 ± 3.58 8.11 ± 3.15 0.419 0.658
lymphocyte count 1.95 ± 1.27 1.76 ± 0.96 1.81 ± 1.07 1.954 0.142
NLR 5.24 ± 3.90 6.41 ± 5.24 7.46 ± 5.51 12.506  < 0.001
NLR tertiles     19.287 0.001
 1st tertile 104 (41.6) 77 (31.3) 64 (26.6)   
 2nd tertile 84 (33.6) 84 (34.1) 77 (32.0)   
 3rd tertile 62 (24.8) 85 (34.6) 100 (41.5)   
Monocyte count 0.59 ± 0.32 0.58 ± 0.32 0.57 ± 0.31 0.258 0.773
PLR 158.09 ± 122.37 176.51 ± 159.31 166.74 ± 142.57 1.042 0.353
RBC 4.75 ± 0.70 4.74 ± 0.73 4.79 ± 0.72 0.399 0.672
HGB 145.15 ± 24.97 142.77 ± 27.85 144.62 ± 24.6 0.579 0.561
PLT 223.74 ± 69.67 242.01 ± 203.23 224.52 ± 77.66 1.508 0.222
MPV 10.20 ± 1.29 10.16 ± 1.75 10.2 ± 1.28 0.065 0.937
PDW 13.66 ± 3.35 13.44 ± 3.78 12.98 ± 3.63 2.298 0.101
PCT 0.24 ± 0.08 0.24 ± 0.11 0.24 ± 0.10 0.239 0.788
Clinical diagnosis     1.672 0.796
 UA 38 (15.2) 32 (13.0) 30 (12.4)   
 NSTEMI 32 (12.8) 26 (10.6) 29 (12.0)   
 STEMI 180 (72.0) 188 (76.4) 182 (75.5)   
 Aspirin 18 (7.2) 23 (9.3) 33 (13.7) 5.923 0.052
 Statins 17 (6.8) 19 (7.7) 31 (12.9)ab 6.029 0.043
 β-Blockers 15 (6.0) 12 (4.9) 17 (7.1) 1.027 0.598
 ACEI/ARB 7 (2.8) 8 (3.3) 12 (5.0) 1.828 0.401
 CCB 32 (12.8) 34 (13.8) 36 (14.9) 0.470 0.790
  1. Abbreviations are as in Table 1